These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31612067)

  • 1. Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model.
    Chen B; Xu M; Xu M
    Oncol Lett; 2019 Nov; 18(5):5600-5606. PubMed ID: 31612067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deleted in liver cancer-1 inhibits cell growth and tumorigenicity in human pancreatic cancer.
    Zheng Z; Tan C; Xiang G; Mai G; Liu X
    Oncol Lett; 2013 Aug; 6(2):521-524. PubMed ID: 24137359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
    Wang C; Wang J; Liu H; Fu Z
    Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
    J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLC-3 suppresses cellular proliferation, migration, and invasion in triple-negative breast cancer by the Wnt/β-catenin pathway.
    Kong B; Lv ZD; Xia J; Jin LY; Yang ZC
    Int J Clin Exp Pathol; 2019; 12(4):1224-1232. PubMed ID: 31933937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth.
    Durkin ME; Ullmannova V; Guan M; Popescu NC
    Oncogene; 2007 Jul; 26(31):4580-9. PubMed ID: 17297465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.
    Yuan BZ; Zhou X; Durkin ME; Zimonjic DB; Gumundsdottir K; Eyfjord JE; Thorgeirsson SS; Popescu NC
    Oncogene; 2003 Jan; 22(3):445-50. PubMed ID: 12545165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1.
    Ng IO; Liang ZD; Cao L; Lee TK
    Cancer Res; 2000 Dec; 60(23):6581-4. PubMed ID: 11118037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated overexpression of TGF-β inducible early gene 1 inhibits SW1990 pancreatic cancer cell growth.
    Jiang L; Wang F; Lin F; Gao SM; Tan Y; Han Y; Chen C; Wu J
    Cell Biol Int; 2011 Sep; 35(9):891-6. PubMed ID: 21524276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line.
    Jin Y; Tian X; Shang Y; Huang P
    Oncol Rep; 2008 Mar; 19(3):669-74. PubMed ID: 18288400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.
    Zhou J; Song S; Cen J; Zhu D; Li D; Zhang Z
    Oncol Res; 2012; 20(5-6):197-203. PubMed ID: 23581226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
    Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
    Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer.
    Hoshi H; Sawada T; Uchida M; Saito H; Iijima H; Toda-Agetsuma M; Wada T; Yamazoe S; Tanaka H; Kimura K; Kakehashi A; Wei M; Hirakawa K; Wanibuchi H
    Int J Oncol; 2011 Mar; 38(3):619-27. PubMed ID: 21249315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eckol inhibits Reg3A-induced proliferation of human SW1990 pancreatic cancer cells.
    Zhang M; Zhou W; Zhao S; Li S; Yan D; Wang J
    Exp Ther Med; 2019 Oct; 18(4):2825-2832. PubMed ID: 31572529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
    Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
    Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
    Li N; Wang C; Zhang P; You S
    Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of transferred NK4 gene on biological characteristics of human pancreatic cancer cell line SW1990].
    Lai RX; Yuan SZ; Nakamura T
    Ai Zheng; 2004 Oct; 23(10):1134-8. PubMed ID: 15473922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
    Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
    Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.